Besides, silencing Wnt3a significantly inhibited the xenograft growth, along with the down-regulation of proliferation marker Ki67, suggesting that Wnt3a could be a promising and effective target for HCC therapy. This evidence concerns the gene MKI67 and hepatocellular carcinoma.